Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis; Comparative Clinical Study

NCT07636057 is registered in ClinicalTrials.gov with Sheikh Zayed Federal Postgraduate Medical Institute as lead sponsor.

NCT NCT07636057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07636057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of Tofacitinib Versus Upadacitinib as Add-on to Methotrexate in Rheumatoid Arthritis; Comparative Clinical Study
Lead sponsor
Sheikh Zayed Federal Postgraduate Medical Institute
Phase
Phase 4
Overall status
Not yet recruiting
Start date
July 5, 2026
Completion date
May 10, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis (ra)